Autism Research Today is a free monthly online journal that collates and summarizes the latest research about Autism, including details on symptoms, diagnosis, treatment, causes, effects.

Deferred and immediate imitation in regressive and early onset autism.

Rogers SJ, Young GS, Cook I, Giolzetti A, Ozonoff S

The MIND Institute, University California Davis, Sacramento, CA 95817, USA. sally.rogers@ucdmc.ucdavis.edu

Deferred imitation has long held a privileged position in early cognitive development, considered an early marker of representational thought with links to language development and symbolic processes. Children with autism have difficulties with several abilities generally thought to be related to deferred imitation: immediate imitation, language, and symbolic play. However, few studies have examined deferred imitation in early autism. The present study examined both deferred, spontaneous imitation and immediate, elicited imitation on a set of carefully matched tasks in 36 young children with autism: 16 with early onset autism, 20 with regressive autism and two contrast groups, younger typically developing children (n = 20) and age matched children with significant developmental delays (n = 21). Analyses of co-variance controlling for differences in verbal mental age revealed significant main effects for task, but no main effect of group and no interaction of task by group. Deferred imitation scores were lower than immediate imitation scores for all groups. Imitation performance was related to overall intellectual functioning for all groups, and there were moderate and significant relations between imitation in the immediate elicited condition and in the spontaneous deferred condition for all groups. Finally, there were no differences between onset subgroups in imitation scores, suggesting that the two share a similar phenotype involving both types of imitation.

Published 26 March 2008 in J Child Psychol Psychiatry, 49(4): 449-57.
Full-text of this article is available online (may require subscription).

Articles on Autism published 18 March 2008:

SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects.   Mol Psychiatry, 13(4): 385-97.

Autism is a neurodevelopmental disorder with a strong genetic component, probably involving several genes. Genome screens have provided evidence of linkage to chromosome 2q31-q33, which includes the SLC25A12 gene. Association between autism and single-nucleotide polymorphisms in SLC25A12 has been reported in various studies. SLC25A12 encodes the mitochondrial aspartate/glutamate carrier functionally important in neurons with high-metabolic activity. Neuropathological findings and functional ... [Abstract] [Full-text]

Articles on Autism published 12 March 2008:

Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid.   Cereb Cortex, 18(4): 763-70.

Exposure to valproic acid (VPA) during embryogenesis can cause several teratogenic effects, including developmental delays and in particular autism in humans if exposure occurs during the third week of gestation. We examined the postnatal effects of embryonic exposure to VPA on microcircuit properties of juvenile rat neocortex using in vitro electrophysiology. We found that a single prenatal injection of VPA on embryonic day 11.5 causes a significant enhancement of the local recurrent ... [Abstract] [Full-text]

Articles on Autism published 6 March 2008:

Diagnosis of autism spectrum disorders in the first 3 years of life.   Nat Clin Pract Neurol, 4(3): 138-47.

Autism spectrum disorders (ASDs) are a class of neurodevelopmental disorders defined by qualitative impairments in social functioning and communication, often accompanied by repetitive and stereotyped patterns of behavior and interests. The term 'ASD' encompasses autism, pervasive developmental disorder not otherwise specified, and Asperger's syndrome. ASDs show etiologic heterogeneity, and there is no definitive medical test or cure for these conditions. Around 1 in 150 children have an ASD, ... [Abstract] [Full-text]

Articles on Autism published 3 March 2008:

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.   Pediatrics, 121(3): e441-8.

OBJECTIVE: The objective of this study was to provide national estimates of psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders and to examine child and health system characteristics associated with psychotropic medication use. METHODS: This cross-sectional study used Medicaid claims for calendar year 2001 from all 50 states and Washington, DC, to examine 60,641 children with an autism spectrum disorder diagnosis. Logistic regression with random effects ... [Abstract] [Full-text]

Articles on Autism published 29 February 2008:

Diagnostic labelling of autism spectrum disorders in NSW.   J Paediatr Child Health, 44(3): 108-13.

AIM: To describe the use of diagnostic labels by clinicians for children with autism spectrum disorders (ASD) and calculate the label-specific and overall agreement between diagnostic labels and Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) diagnoses provided by the same clinician. METHODS: State-wide active surveillance was used to ascertain children newly recognised with one or more DSM-IV criteria for autistic disorder aged 0-15 years (incident cases) in New ... [Abstract] [Full-text]

Articles on Autism published 28 February 2008:

Clinical presentation and diagnosis of tuberous sclerosis complex in infancy.   J Child Neurol, 23(3): 268-73.

The age-dependent nature of the characteristic features of tuberous sclerosis complex has historically presented challenges for the diagnosis in infancy. Although the increasing availability of neuroimaging and genetic testing has facilitated the diagnosis in neonates and infants, there are few reports describing how tuberous sclerosis complex presents in this age group. We performed a retrospective review of children diagnosed with tuberous sclerosis complex during the first year of life, ... [Abstract] [Full-text]

Autism and metabolic diseases.   J Child Neurol, 23(3): 307-14.

Autism is an etiologic heterogeneous entity caused by many different diseases occurring in the central nervous system at an early stage in life. Several metabolic defects have been associated with autistic symptoms with a rate higher than that found in the general population. Inborn errors of metabolism can probably account for less than 5% of individuals. Selective metabolic testing should be done in the presence of suggestive clinical findings, including lethargy, cyclic vomiting, early ... [Abstract] [Full-text]

Articles on Autism published 14 February 2008:

Association between microdeletion and microduplication at 16p11.2 and autism.   N Engl J Med, 358(7): 667-75.

BACKGROUND: Autism spectrum disorder is a heritable developmental disorder in which chromosomal abnormalities are thought to play a role. METHODS: As a first component of a genomewide association study of families from the Autism Genetic Resource Exchange (AGRE), we used two novel algorithms to search for recurrent copy-number variations in genotype data from 751 multiplex families with autism. Specific recurrent de novo events were further evaluated in clinical-testing data from Children's ... [Abstract] [Full-text]

© 2004-2008 Autism Research Today. All Rights Reserved.